Researchers Find COVID Vaccine Boosts Immunotherapy Response and Survivability
HOUSTON, Oct. 20 – A University of Houston biology student played a pivotal role in a groundbreaking discovery by researchers at MD Anderson Cancer Center: the COVID vaccine can enhance the effectiveness of immunotherapy treatments, offering new hope to cancer patients worldwide.
In a new study presented Oct. 19 at the 2025 European Society for Medical Oncology Congress, researchers revealed patients who received mRNA-based COVID vaccines within 100 days of starting immunotherapy were twice as likely to be alive three years after treatment as those who didn’t receive the vaccine…